NYSE:MDTMedical Equipment
Should Medtronic’s (MDT) Pulsed Field Ablation Milestones Reshape Its Cardiac Rhythm Management Strategy?
In recent weeks, Medtronic reported multiple milestones for its Affera Sphere-360 pulsed field ablation catheter, including CE Mark approval in Europe and completion of first procedures in the U.S. Horizon 360 IDE pivotal trial for treating paroxysmal atrial fibrillation.
This progress highlights Medtronic’s push to integrate an all-in-one mapping and rotation-free ablation approach, potentially improving procedure efficiency and reinforcing its position in cardiac rhythm management.
We’ll...